Stephen S Y Lam

6PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 06, 2026
Quizartinib and omacetaxine mepesuccinate combination therapy in FLT3-ITD AML: a phase II trial.

Li-Chuan Zheng, Kelvin K W Wong, Stephen S Y Lam

|May 21, 2025
Mechanism of Initial Favorable Response to Decitabine in TP53-Mutated MDS/AML and Potential Mechanisms of Subsequent Relapse.

Nelson K L Ng, Stephen S Y Lam, Lichuan Zheng

|Dec 06, 2023
Distinct karyotypic and mutational landscape in trisomy AML.

Stephen S Y Lam, Sze P Tsui, C Y Fung

|Oct 20, 2020
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults.

Sze P Tsui, Ho W Ip, Nicole Y Saw

|Feb 28, 2020
Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML.

Stephen S Y Lam, Anskar Y H Leung

Pageof 1